WestPark Capital Announces the Completion of an $8 Million IPO For INmune Bio, Inc.
/
Date07 Feb 2019
Email Print Friendly Share LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) — WestPark Capital, Inc., the Los Angeles based international investment banking firm, today announced... Read More →
Avedro Launches Initial Public Offering
/
Date04 Feb 2019
Email Print Friendly Share WALTHAM, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) — Avedro, Inc. (“Avedro”), a leading commercial-stage ophthalmic medical technology company focused on treating... Read More →
Changfeng Announces Hong Kong IPO Update and Declaration of Semi-annual and Special Dividends
/
Date31 Jan 2019
Email Print Friendly Share TORONTO, Jan. 30, 2019 (GLOBE NEWSWIRE) — Changfeng Energy Inc., (TSXV: CFY) (“Changfeng” or the “Company”, together with its subsidiaries the... Read More →
MARE NOSTRUM enregistre son document de base auprès de l’Autorité des Marchés Financiers (AMF) – 1ère étape de son projet d’introduction en bourse
/
Date24 Jan 2019
Email Print Friendly Share Ne pas diffuser, directement ou indirectement, aux Etats-Unis, au Canada, en Australie ou au Japon. MARE NOSTRUM enregistre son document de... Read More →
Rexahn Announces Pricing of Public Offering of Common Stock and Warrants
/
Date23 Jan 2019
Email Print Friendly Share ROCKVILLE, Md., Jan. 23, 2019 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE American: RNN) today announced the pricing of an underwritten... Read More →
Boustead Securities and ClickIPO Team Up to Bring the Soliton, Inc. (SOLY) IPO to Potential Subscribers Online with the Free ClickIPO App at the Apple App Store or Google Play Store
/
Date15 Jan 2019
Email Print Friendly Share Los Angeles, CA, Jan. 14, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — ClickIPO Securities, LLC (“ClickIPO”) and Boustead Securities, LLC. (“Boustead”) announced... Read More →
Anchiano Therapeutics Announces Filing of F-1 Registration Statement for U.S. Initial Public Offering
/
Date08 Jan 2019
Email Print Friendly Share CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) — Anchiano Therapeutics Ltd. (TASE: ANCN), a clinical-stage biopharmaceutical company focused on the discovery... Read More →
Amerant Closes Initial Public Offering
/
Date21 Dec 2018
Email Print Friendly Share CORAL GABLES, Fla., Dec. 21, 2018 (GLOBE NEWSWIRE) — Mercantil Bank Holding Corporation (NASDAQ: AMTB and AMTBB) (the “Company”) announced today... Read More →
MannKind Announces Commencement of Public Offering
/
Date20 Dec 2018
Email Print Friendly Share WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced that it has commenced an... Read More →
Amerant Announces Pricing of Initial Public Offering
/
Date19 Dec 2018
Email Print Friendly Share CORAL GABLES, Fla., Dec. 18, 2018 (GLOBE NEWSWIRE) — Mercantil Bank Holding Corporation (NASDAQ: AMTB and AMTBB) (the “Company”) announced today... Read More →